Cannabis oil extracts for chronic pain: what else can be learned from another structured prospective cohort?
Sublingual THC:CBD oil extracts administered at modest, individually titrated daily doses (around 20 mg each) provided statistically significant.
Cannabinoid therapeutics in orofacial pain management: a systematic review
While current systemic and oral cannabinoid formulations lack robust evidence for managing acute orofacial and post-operative dental pain.
A within-subject, double-blind, placebo-controlled randomized evaluation of the combined effects of cannabidiol and hydromorphone in a human laboratory pain model
In this double-blind laboratory study, low-dose oral cannabidiol (50 mg) enhanced the acute analgesic properties of 4 mg hydromorphone without increasing.
Association between personality traits and placebo effects: a preregistered systematic review and meta-analysis
This systematic review and meta-analysis demonstrates that standard personality traits do not reliably predict placebo responsiveness.
